Michael F. Huang

Sr. VP of Clinical Development · 2 filings · Latest: May 18, 2026

SOLENO THERAPEUTICS INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SLNO	Michael F. Huang	Sr. VP of Clinical Development	May 18, 2026	Disposition	—	39,823	—	0	May 18 4:38 PM
SLNO	Michael F. Huang	Sr. VP of Clinical Development	Mar 27, 2026	Sale	$30.44	6,582	$200.4K	39,823	Mar 31 8:15 PM